Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Angiodynamics Inc Announces Management Changes
Angiodynamics Inc announced that Executive Vice President and Chief Financial Officer Joseph Gersuk will retire from the Company on January 31, 2013. He will be succeeded by Mark T. Frost, who was recently Chief Financial Officer and Senior Vice President of Administration of Albany Molecular Research Inc.
Latest Developments for AngioDynamics Inc
- Angiodynamics Inc Lowers FY 2013 Guidance
- Angiodynamics Inc Issues Q3 2013 Guidance Below Analysts' Estimates
- Angiodynamics Inc Sees FY 2013 Revenue Guidance To A Slightly Lower Midpoint Of Prior Range; Reaffirms FY 2013 EPS Guidance-Conference Call
- Angiodynamics Inc Reaffirms FY 2013 Guidance; Lowers FY 2013 Revenue And EBITDA Guidance
- Share this
- Link this
- Digg this
Follow Reuters